Standard therapy may present some detrimental aspects such as tissue damage, hypoxia and cancer cell apoptosis through the release of proinflammatory cytokines such as TNF-alpha, granulocyte-colony stimulating factor (G-CSF), CXCL12, CCL2-4 and ICAM1 [40]. This evidence concerns the gene ICAM1 and cancer.